Dd. Smyth et Sb. Penner, RENAL I-1-IMIDAZOLINE RECEPTOR-SELECTIVE COMPOUNDS MEDIATE NATRIURESIS IN THE RAT, Journal of cardiovascular pharmacology, 26, 1995, pp. 63-67
In the present study, we investigated the renal actions of two compoun
ds reported to interact with the imidazoline receptor: rilmenidine (I-
1-receptor selective, centrally acting antihypertensive) and agmatine
(an endogenous clonidine-displacing substance). Rilmenidine (saline ve
hicle, 3 or 30 nmol/kg/min) or agmatine (saline vehicle, 3 or 30 nmol/
kg/min) was infused directly into the renal artery of anesthetized (pe
ntobarbitone) Sprague-Dawley rats (280-300 g) that had undergone a uni
lateral nephrectomy 7 to 10 days before the experiment, Rilmenidine pr
oduced an increase in urine flow rate at doses that failed to signific
antly alter blood pressure, creatinine clearance, or heart rate. The i
ncrease in urine flow rate was secondary to an increase in osmolar cle
arance, primarily composed of sodium. Free water clearance was not alt
ered at these infusion rates. Agmatine also increased urine flow rate
at doses that failed to alter blood pressure, creatinine clearance, an
d heart rate. The increase in urine flow rate was secondary to an incr
ease in osmolar clearance, again primarily composed of sodium. The nat
riuretic action of rilmenidine and agmatine, at doses that do not lowe
r blood pressure acutely, could be beneficial in the antihypertensive
actions of these centrally acting agents.